Country websites:

Attention

The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all Asia Pacific countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.

FX Dialyzers — Blue makes a difference

FX Dialyzers — Blue makes a difference

"Small details can make a big difference in medical outcomes."

Why FX Dialyzers make a difference

FX Dialyzers have been used in more than 500 million treatments worldwide. As the world’s leading provider of dialysis products, Fresenius Medical Care aims to make a difference — for patients and healthcare professionals.

Continuous innovation combined with our commitment to the highest level of quality standards, ensure that our FX Dialyzers portfolio is built to address the individual needs of patients. 

FX Dialyzers

FX portfolio

All FX Dialyzers have the capacity to remove a broad range of uremic toxins, effectively retain endotoxins, and provide intrinsic biocompatibility.1

Nurse - treatment quote for FX Dialyzers

 

"A smooth treatment is the difference that allows us to focus more on the patient."

FX properties that make a difference

Several state-of-the-art technologies have been combined to create the distinctive functional properties of the FX Dialyzers. Together they make a difference in terms of beneficial patient outcomes, smooth handling and cost savings potential.

Two FX-Dialyzers on side
  • 1. Lateral blood inlet port
  • 2. System compatibility and more
  • 3. Sophisticated fiber architecture
  • 4. Optimized header design
  • 5. INLINE steam sterilization
  • 6. Sustainable product design

Smooth handling

Simplified workflows

Improved clearances

Enhanced performance

Setting the standard

Adding value across the entire life cycle

Patient - treatment quote for FX Dialyzers

 

"The difference is feeling confident throughout the entire treatment."

FX blue art project

Dialyzers are life-saving pieces of medical and technological art. The advanced design of the FX Dialyzers adds a dimension that reflects the thought, care and quality that went into its construction. As the most prominent visible characteristic, the color blue of the FX Dialyzer caps became the inspiration point for our unique blue art project. We asked artists to interpret the benefits of the FX Dialyzers in their own way — be it figurative or abstract, poetic or surreal, two- or three-dimensional — with stunning results.

Each artist granted another level of meaning, a unique interpretation or a new perspective to apply to the distinctive functional properties of the FX Dialyzers. Warm and sensitive, intellectual and meaningful approaches came to life.

 

FIND OUT MORE

Art gallery

Hospital Head - treatment quote for FX Dialyzers

 

"Reliability and experience make a difference when seeking the best solutions."

1 Wagner S. et al., Nephrology Dialysis Transplantation (2017); 32 (3): iii615.
2 Bock A. et al., J Am Soc Nephrol (2013); 24: SA-PO404.
3 Maduell F. et al., Blood Purif. (2014); 37(2): 125-130.
4 Lim P. S. et al., Artif Organs (2017); Nov 27. doi: 10.1111/aor.13011.
5 Schindler R. et al., Clin. Nephrology (2003); 59: 447–454.
6 Weber V. et al., Artif Organs (2004); 28(2): 210-217.
7 Chazot C. et al., Nephron (2015); 129: 269-275.
8 Tsai I.J. et al., Pediatr Nephrol (2014); 29: 111–116.
9 Data from Fresenius Medical Care Deutschland GmbH: Comparison clearance values F8 HPS (effective surface area 1.8 m2) versus FX 8 (effective surface area 1.4 m2).
10 Ronco C., Nissenson A. R., Blood Purif (2001); 19: 347-352.
11 Ronco C. et al., Kidney International (2002); 61 (80): 126-142.
12 Külz M. et al., Nephrol Dial Transplant (2002); 17: 1475-1479.
13 Mandolfo S. et al., The International Journal of Artificial Organs (2003); 26 (2): 113-120.
14 Allard B. et al., Le Pharmacien Hospitalier et Clinicien (2013); 48 (4): 15-21.
15 Shintani H., Biomedical instrumentation & technology (1995); 29 (6): 513–519.
16 Hirata N. et al., Radiation Physics and Chemistry (1995); 46 (3): 377–381.
17 Golli-Bennour E. E. et al., International urology and nephrology (2011); 43 (2): 483–490.
18 Azzabi A. et al., Néphrologie & Thérapeutique (2014); 10 (5): 318.
19 Golli-Bennour E.E et al., World J Nephrol Urol (2017); 6 (1-2): 14-17.
20 da Silva Aquino K. A., INtechOpen (2012); www.intechopen.com/books/gamma-radiation/sterilization-by-gamma-irradiation (27.04.2018).
21 Dawids S., Handlos V. N., Developments in hematology and immunology (1989); 347–368.
22 Unpublished data from Fresenius Medical Care Deutschland GmbH: Internal calculation based on weight measurements before treatment of FX Dialysers versus F-series dialysers.
23 Unpublished data from Fresenius Medical Care Deutschland GmbH: Internal calculation based on weight measurements of FME FX classix 80 versus FME HF 80S. The typical number of treatments in most clinics is approximately 10,000 per year; this results in about 1,600 kg less waste being produced annually with FX classix 80 when used on FME 5008 CorDiax machine.
24 EC-JRC-IES (2011): ILCD handbook – Recommendations for LCIA in the European context. Source: publications.jrc.ec.europa.eu/repository/handle/JRC61049 (all 15 environmental impact categories with recommendation in table 1 of this ILCD handbook have been evaluated).
25 Unpublished data from Fresenius Medical Care Deutschland GmbH internal study (2018): Comparative life cycle assessment of selected FME dialysers. Eco-performance is always calculated versus baseline product (FME HF 80S); long distance scenario illustrated.

In this section: